HSPA5 and neoplasm: Aside from the extensively described roles in tumor progression, our data suggest that downregulation of GRP78 may represent a suitable therapeutic intervention strategy for modulating tumor-microenvironment adhesive interactions leading to tumor progression and drug resistance.